BIOMAT Database Logo BIOMAT Database Logo

13-cis-retinoic acid-associated bone marrow edema in neuroblastoma. 2012

Yuya Sato, and Shigeko Kuwashima, and Hidemitsu Kurosawa, and Kenichi Sugita, and Keitaro Fukushima, and Osamu Arisaka

UI MeSH Term Description Entries
D008297 Male Males
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D001855 Bone Marrow Diseases Diseases involving the BONE MARROW. Bone Marrow Disease,Disease, Bone Marrow,Diseases, Bone Marrow,Marrow Disease, Bone,Marrow Diseases, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000842 Ankle The region of the lower limb between the FOOT and the LEG. Tarsus,Regio tarsalis,Ankles
D015474 Isotretinoin A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects. 13-cis-Retinoic Acid,Accutane,Isotretinoin Zinc Salt, 13-cis-Isomer,Ro 4-3780,Roaccutane,13 cis Retinoic Acid,Isotretinoin Zinc Salt, 13 cis Isomer,Ro 4 3780,Ro 43780

Related Publications

Yuya Sato, and Shigeko Kuwashima, and Hidemitsu Kurosawa, and Kenichi Sugita, and Keitaro Fukushima, and Osamu Arisaka
13-cis-retinoic acid-induced eosinophilia following autologous bone marrow transplantation for neuroblastoma.
April 1999, Medical and pediatric oncology,
Yuya Sato, and Shigeko Kuwashima, and Hidemitsu Kurosawa, and Kenichi Sugita, and Keitaro Fukushima, and Osamu Arisaka
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
April 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Yuya Sato, and Shigeko Kuwashima, and Hidemitsu Kurosawa, and Kenichi Sugita, and Keitaro Fukushima, and Osamu Arisaka
Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation.
January 1996, Cancer chemotherapy and pharmacology,
Yuya Sato, and Shigeko Kuwashima, and Hidemitsu Kurosawa, and Kenichi Sugita, and Keitaro Fukushima, and Osamu Arisaka
Human neuroblastoma cells and 13-cis-retinoic acid.
January 1985, Journal of neuro-oncology,
Yuya Sato, and Shigeko Kuwashima, and Hidemitsu Kurosawa, and Kenichi Sugita, and Keitaro Fukushima, and Osamu Arisaka
Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma.
December 2014, British journal of pharmacology,
Yuya Sato, and Shigeko Kuwashima, and Hidemitsu Kurosawa, and Kenichi Sugita, and Keitaro Fukushima, and Osamu Arisaka
13-cis-retinoic acid and bone density.
October 1995, International journal of dermatology,
Yuya Sato, and Shigeko Kuwashima, and Hidemitsu Kurosawa, and Kenichi Sugita, and Keitaro Fukushima, and Osamu Arisaka
Spontaneous fractures during 13-cis retinoic acid therapy for neuroblastoma.
May 2023, Pediatric blood & cancer,
Yuya Sato, and Shigeko Kuwashima, and Hidemitsu Kurosawa, and Kenichi Sugita, and Keitaro Fukushima, and Osamu Arisaka
Hypercalcemia induced by 13 cis-retinoic acid in patients with neuroblastoma.
April 2008, Pediatrics international : official journal of the Japan Pediatric Society,
Yuya Sato, and Shigeko Kuwashima, and Hidemitsu Kurosawa, and Kenichi Sugita, and Keitaro Fukushima, and Osamu Arisaka
The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
January 2001, Medical and pediatric oncology,
Yuya Sato, and Shigeko Kuwashima, and Hidemitsu Kurosawa, and Kenichi Sugita, and Keitaro Fukushima, and Osamu Arisaka
Comparison of 13-cis-retinoic acid to trans-retinoic acid using human neuroblastoma cell lines.
January 1994, Progress in clinical and biological research,
Copied contents to your clipboard!